ProfileGDS4095 / 220527_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 59% 61% 64% 61% 64% 63% 61% 61% 65% 66% 61% 63% 63% 60% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep14.6075659
GSM709769LY2 SRC1-siRNA tamoxifen treated rep34.9831861
GSM709765LY2 SRC1-siRNA untreated rep35.5897364
GSM709771LY2 SRC1-siRNA untreated rep14.9947861
GSM709772LY2 SRC1-siRNA untreated rep25.4895664
GSM709775LY2 SRC1-siRNA untreated rep45.2980863
GSM709764LY2 control-siRNA tamoxifen treated rep24.8592861
GSM709766LY2 control-siRNA tamoxifen treated rep34.9003461
GSM709768LY2 control-siRNA tamoxifen treated rep15.6934665
GSM709777LY2 control-siRNA tamoxifen treated rep45.8761666
GSM709770LY2 control-siRNA untreated rep35.0138561
GSM709773LY2 control-siRNA untreated rep15.2738463
GSM709774LY2 control-siRNA untreated rep25.287763
GSM709776LY2 control-siRNA untreated rep44.8216960